Results for tag: "Ischemic Attack Drug"

The Ischemic Attack Drug market is a subset of the Cardiovascular Drugs market, which focuses on drugs used to treat ischemic attacks, also known as ischemic strokes. Ischemic attacks are caused by a blockage in the blood vessels that supply blood to the brain, and can lead to permanent brain damage or death. Ischemic attack drugs are used to reduce the risk of stroke and improve the patient's quality of life. These drugs can be administered orally, intravenously, or through a catheter. Commonly used ischemic attack drugs include aspirin, clopidogrel, and ticagrelor. Some of the major companies in the Ischemic Attack Drug market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and GlaxoSmithKline. These companies produce a variety of ischemic attack drugs, including aspirin, clopidogrel, and ticagrelor. Show Less Read more